Obtainment of results for the 3rd group of volunteers in the 1st phase of clinical trials

We have obtained results for the 3rd group of volunteers in the 1st phase of clinical trials of the Amidine hydrochloride dosage form (DD217). Number of volunteers - 6 people. Administration - 60 mg once, orally. Preliminary results - serious adverse events haven’t been observed.